NUTM2A and neoplasm: Treatment of HepG2 cells with curcumin (at half‐inhibitory concentrations) led to significant upregulation of tumor‐suppressive miRNAs (miR‐195, miR‐15a/16, and miR‐424) and concurrent downregulation of NUTM2A‐AS1, HCG18, and miR‐15b‐5p.